US Healthcare Journal
SEE OTHER BRANDS

Get your fresh news on healthcare and wellness in the United States

US Healthcare Journal: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on US Healthcare Journal.

Press releases published on July 2, 2025

Hereditary Angioedema (HAE): Competitive Intelligence Insight into Next-Gen Treatment Strategies | DataM Intelligence

Hereditary Angioedema (HAE): Competitive Intelligence Insight into Next-Gen Treatment Strategies | DataM Intelligence

HAE care evolving with tailored prophylaxis, long-acting biologics, …

Skin Biopsy Market  Outlook: Innovations Reshaping Healthcare

Skin Biopsy Market Outlook: Innovations Reshaping Healthcare

PORTLAND, IL, UNITED STATES, July 2, 2025 /⁨EINPresswire.com⁩/ -- According to the report published by Allied Market Research, the global skin biopsy market was valued at $101.2 million in 2021, and is projected to reach $181.58 million by 2031, …

Rising Demand in the Blood Bank Information Systems Market: Key Drivers & Forecast 2031

Rising Demand in the Blood Bank Information Systems Market: Key Drivers & Forecast 2031

PORTLAND, DE, UNITED STATES, July 2, 2025 /⁨EINPresswire.com⁩/ -- A new business intelligence report released by Allied Market Research, the global Blood Bank Information Systems Market generated $557.2 million in 2021 and is estimated to hit $1.1 billion …

Veterinary Pain Management Market Growth, Opportunities, Industry Applications, Analysis and Forecast by 2032

Veterinary Pain Management Market Growth, Opportunities, Industry Applications, Analysis and Forecast by 2032

Veterinary Pain Management Market Was valued at USD 2.2 Bn. in 2024 is expected to grow at CAGR 6.5 % from 2025 to 2032 Reaching nearly 3.64 Bn. by 2032 SAN DIEGO, CA, UNITED STATES, July 2, 2025 /⁨EINPresswire.com⁩/ -- Stellar Market Research examines …

 Senior Care Expert Launches Hometown Senior Placement in Florida

Senior Care Expert Launches Hometown Senior Placement in Florida

Elizabeth Brennen, a second-generation registered nurse, is proud to introduce Hometown Senior Placement, specializing in dementia and geriatric care. PALM BEACH GARDENS, FL, UNITED STATES, July 2, 2025 /⁨EINPresswire.com⁩/ -- Ms. Brennen, a Palm Beach …

Range Impact Announces Expansion of Investment in its Fola Mine Complex with Acquisition of Two Mining Permits and Two Coal Leases

Range Impact Announces Expansion of Investment in its Fola Mine Complex with Acquisition of Two Mining Permits and Two Coal Leases

CLEVELAND, OHIO, July 02, 2025 (GLOBE NEWSWIRE) -- Range Impact, Inc. (OTCQB: RNGE) (“Range Impact” or the “Company”), a public company dedicated to acquiring, reclaiming and repurposing distressed coal mines throughout Appalachia, today announced the …

Business Reporter: Infusing market research with agility

Business Reporter: Infusing market research with agility

BoltChatAI – an AI-moderated, qualitative-research-at-scale platform LONDON, UNITED KINGDOM, July 2, 2025 /⁨EINPresswire.com⁩/ -- In an article published on Business Reporter, Hakan Yurdakul, CEO of Bolt Insight talks about how BoltChatAI, the company’s …

Vertigo Treatment Market Expected To Grow at a CAGR of 5.23 % From 2025 to 2032

Vertigo Treatment Market Expected To Grow at a CAGR of 5.23 % From 2025 to 2032

Vertigo Treatment Market revenue is expected to grow at a CAGR of 5.23 % from 2025 to 2032, reaching nearly USD 2.66 Bn by 2032. MIAMI, FL, UNITED STATES, July 2, 2025 /⁨EINPresswire.com⁩/ -- Stellar Market Research examines the growth rate of the Vertigo …

Generalized Myasthenia Gravis 2025: From Broad Immunosuppression to Targeted Biologics and Cellular Therapies

Generalized Myasthenia Gravis 2025: From Broad Immunosuppression to Targeted Biologics and Cellular Therapies

gMG care is shifting from steroids to targeted therapies-complement inhibitors, Fc modulators, cell therapies offering improved safety and durability in 2025. AUSTIN, TX, UNITED STATES, July 2, 2025 /⁨EINPresswire.com⁩/ -- Generalized Myasthenia Gravis ( …

Global Handheld Multi-Parameter Monitoring Device Market Set For 7.9% Growth, Reaching $5 Billion By 2029

Global Handheld Multi-Parameter Monitoring Device Market Set For 7.9% Growth, Reaching $5 Billion By 2029

The Business Research Company's Global Handheld Multi-Parameter Monitoring Device Market Set For 7.9% Growth, Reaching $5 Billion By 2029 LONDON, GREATER LONDON, UNITED KINGDOM, July 2, 2025 /⁨EINPresswire.com⁩/ -- Save 30% on all global market reports …

Global Fulvestrant Injection Market Outlook 2025-2034: Growth Drivers, Share, And Trends

Global Fulvestrant Injection Market Outlook 2025-2034: Growth Drivers, Share, And Trends

The Business Research Company’s Fulvestrant Injection Global Market Report 2025 – Market Size, Trends, And Forecast 2025-2034 LONDON, GREATER LONDON, UNITED KINGDOM, July 2, 2025 /⁨EINPresswire.com⁩/ -- The world of pharmaceuticals has seen the …

Amyotrophic Lateral Sclerosis (ALS): Competitive Intelligence Insight into Next-Gen Therapies | DataM Intelligence

Amyotrophic Lateral Sclerosis (ALS): Competitive Intelligence Insight into Next-Gen Therapies | DataM Intelligence

ALS treatment is evolving from symptom management to disease-modifying strategies gene therapies, antisense drugs, …

Major Gabapentin Market Trend 2025: Advancements Bioequivalent Gabapentin Tablets Boost Neurological Treatment Options

Major Gabapentin Market Trend 2025: Advancements Bioequivalent Gabapentin Tablets Boost Neurological Treatment Options

The Business Research Company’s Gabapentin Global Market Report 2025 – Market Size, Trends, And Forecast 2025-2034 LONDON, GREATER LONDON, UNITED KINGDOM, July 2, 2025 /⁨EINPresswire.com⁩/ -- What Is The Current Scenario Of The Gabapentin Market And Its …

Portable Ultrasound Devices Market Size To Reach USD 8.06 Billion by 2032, at a CAGR of 4.5% To Forecast 2025-2032

Portable Ultrasound Devices Market Size To Reach USD 8.06 Billion by 2032, at a CAGR of 4.5% To Forecast 2025-2032

Portable Ultrasound Device Market was valued at USD 5.67 Bn in 2024 and is expected to reach USD 8.06 Bn by 2032, at a CAGR of 4.5% during the forecast period WILMINGTON, DE, UNITED STATES, July 2, 2025 /⁨EINPresswire.com⁩/ -- Stellar Market Research …

Business Reporter: Unmeasured events cost you

Business Reporter: Unmeasured events cost you

How event agency emc3 helps marketers prove event impact and secure further investment LONDON, UNITED KINGDOM, July 2, 2025 /⁨EINPresswire.com⁩/ -- In an article published on Business Reporter, events agency, emc3, challenges the status quo: why are so …

Praxis Precision Medicines, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Praxis Precision Medicines, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

BOSTON, July 02, 2025 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (Nasdaq: PRAX), a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for central nervous system (CNS) disorders characterized by …

Xilio Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Xilio Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

WALTHAM, Mass., July 02, 2025 (GLOBE NEWSWIRE) -- Xilio Therapeutics, Inc. (Nasdaq: XLO), a clinical-stage biotechnology company discovering and developing tumor-activated immuno-oncology therapies for people living with cancer, today announced that, …

Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

SAN FRANCISCO, July 02, 2025 (GLOBE NEWSWIRE) -- Olema Pharmaceuticals, Inc. (“Olema” or “Olema Oncology”, Nasdaq: OLMA), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of targeted therapies for …

Oragenics Completes Approximately $16.5 Million Offering

Oragenics Completes Approximately $16.5 Million Offering

SARASOTA, Fla., July 02, 2025 (GLOBE NEWSWIRE) -- Oragenics, Inc. (NYSE American: OGEN), a clinical-stage biotechnology company pioneering intranasal therapeutics for neurological disorders, today announced the successful closing of its previously …

Cellectar Biosciences Announces Closing of $6.9 Million Underwritten Public Offering, including Full Exercise of Over-Allotment Option

Cellectar Biosciences Announces Closing of $6.9 Million Underwritten Public Offering, including Full Exercise of Over-Allotment Option

FLORHAM PARK, N.J., July 02, 2025 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (Nasdaq: CLRB) (the “Company”), a late-stage clinical biopharmaceutical company focused on the discovery and development of drugs for the treatment of cancer, today announced …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service